Showing results (461-470 of 686) with videos related to
Sort By:
Pageof 69
Nature Communications|September 1, 2023
Transcranial focused ultrasound-mediated neurochemical and functional connectivity changes in deep cortical regions in humansSiti N Yaakub, Tristan A White, Jamie Roberts, et al.Iucrj|June 11, 2024
Scanning WAXS microscopy of regenerated cellulose fibers at mesoscopic resolutionSara Johansson, Francesco Scattarella, Sebastian Kalbfleisch, et al.The Journal of Rheumatology|July 9, 2008
Drug use and toxicity in psoriatic disease: focus on methotrexateWilliam J Taylor, Eleanor Korendowych, Peter Nash, et al.RMD Open|May 28, 2021
Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposureGerd R Burmester, Peter Nash, Bruce E Sands, et al.Rheumatology and Therapy|March 13, 2022
Experiences and Treatment Preferences in Patients With Psoriatic Arthritis: A Cross-Sectional Study in the ArthritisPower RegistryAlexis Ogdie, Kelley Myers, Carol Mansfield, et al.Rheumatology and Therapy|October 18, 2021
Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2Vibeke Strand, Filip Van den Bosch, Roberto Ranza, et al.Rheumatology and Therapy|December 18, 2021
Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with TofacitinibAra Dikranian, David Gold, Louis Bessette, et al.Plos One|November 9, 2013
Nutrient regulation by continuous feeding removes limitations on cell yield in the large-scale expansion of Mammalian cell spheroidsBradley P Weegman, Peter Nash, Alexandra L Carlson, et al.Lupus Science & Medicine|December 8, 2017
Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trialSomnath Bandyopadhyay, Sean E Connolly, Omar Jabado, et al.Clinical Rheumatology|April 19, 2018
Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitorsKathleen Tymms, Geoff Littlejohn, Hedley Griffiths, et al.Pageof 69